Jlang,
Feel free to continue with the ad hominem
Jlang,
Feel free to continue with the ad hominem attacks. Your ascribing of Dunning Kruger effect to me is laughable projection, but each to his own. I don’t imagine that these behaviors will result in a second opportunity to me moderator.
Your continued dismissal of viral replication and mutation rates as moot remains unfounded. Please explain how variants are able to develop, without mutations from which selective pressures can choose the new and more fit.
Selective pressure in the immune compromised favors variants that succeed against the impaired immune systems of those same compromised patients. The strength of selective pressures matters. This is the basis for the development of variants of concern as poised to lesser variants of interest and simple genetic drift.
More broadly in medicine, the immunocompromised contribute to the development of resistance to effective drugs, as the host immune system is unable to eradicate the circulating population of pathogens, selecting for resistance to the administered drug. Without a drug against which to develop resistance or a robust immune response to evade, there is little to drive change.
Covid circulating unchecked across the world with known case well over 200M provides ample opportunity for mutations to drive emergence of variants.
Perhaps a better, more compressible analogy is the development of fighting prowess. Which will be the more formidable opponent, he who has spent a year fighting other seasoned combatants in a tough neighborhood (normal immune system) or one who has spent 20 years terrorizing kindergarten playgrounds (immune suppressed)? Success against a weakened opponent generates ability to succeed against a weakened opponent.
I agree in part with your statement that,
“ Healthy hosts don't allow the virus as much time to "pick the lock" or increase affinity.. immunocompromised hosts do. Immunocompromised hosts allow the virus several bites at that apple, merely swatting it away instead of smashing it outright.”
However, hundreds of millions of immune competent patients have contracted Covid, selecting for variants able to “pick the lock” of a formidable emplacements, not simply break into a wet paper bag.
The immunocompromised do constitute an ongoing reservoir of viral replication and resultant mutation. Stamping that out worldwide is necessary and unfortunately is not likely to happen with current vaccines.
Spike targeting vaccines select for revolution of variants with novel spike confirmations. We collectively have likely made a mistake by not designing vaccines with inactivated Covid virions or multiple expressed antigens.
Valenva among others is developing an inactivated whole virus vaccine. Fingers crossed that this is the vaccine that may allow true control of the circulation of Covid.
5
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...
Continue Reading
NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...
Continue Reading
If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...
Continue Reading
Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...
Continue Reading
Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...
Continue Reading
A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...
Continue Reading
China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...
Continue Reading
NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...
Continue Reading
Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...
Continue Reading
Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...
Continue Reading
Top 5 Most Recently Viewed Articles
H.I.G. Realty Collaborates with Queen Mary BioEnterprises H.I.G. Capital, a prominent global alternative investment firm with an impressive $67 billion in capital under management, has exciting news to share. They have entered a strategic partnership with Queen Mary BioEnterprises Innovation Centre, located in the bustling area of Whitechapel, London. This collaboration...
Continue Reading
Riding High with a Safety Record and Cash Reserves Hycroft Mining Holding Corporation isn't just treading water—they're swimming strong, closing out Q2 of 2026 with zero injuries and a whopping $220.5 million in the bank. No debt, zero accidents, and 1.4 million work hours without an incident—those are numbers you don't just stumble upon. This is a sign of a company...
Continue Reading
Exciting Collaboration Between Financial Associations for 2026 Financial Executives International (FEI) and the Media Financial Management Association (MFM) have made a significant announcement about their 2026 Annual Conference. This event is set to be a landmark occasion as they will co-locate and co-brand the conference, bringing in financial leaders from across...
Continue Reading
Revolutionary Gene-Editing Therapy for Hyperlipidemia Unveiled CorrectSequence Therapeutics' CS-121 Completed Dosing of First Chylomicronemia Patient, Demonstrating Excellent Safety and Significant Efficacy In a groundbreaking announcement, CorrectSequence Therapeutics Co., Ltd. has reported a notable milestone in the medical field. The completion of dosing for the first...
Continue Reading
Socket Mobile Launches CaptureSDK 2.0 for Enhanced Data Capture Socket Mobile, Inc. (NASDAQ: SCKT), a prominent player in the data capture industry, has made a significant leap forward with the introduction of CaptureSDK 2.0. This robust software solution sets the stage for a new generation of efficient and cost-effective barcode scanners that promise to benefit both...
Continue Reading